3 important factors that make or break your practice’s online reputationJulie Gough-Nelson shares the three important things worth remembering in an era of online reviews for best-practice management.
Should your practice have a blog?
Should your practice have a blog?Most physicians have incredibly hectic work lives filled with people (the sheer number of patients seen daily), conditions (the vast amount of diagnoses made per week), and stories (the close calls, exciting cases and thrills of practicing medicine), so it seems only natural physicians have a lot to blog about.
Descemet, Munson, Bowman, and more
How to ensure your new employees are on the right trackFind out how to get your new staff members started on the right foot from Day One.
[BLOG]: Diagnostics as aids for specialty drug treatmentLaboratory diagnostics are essential tools of physician practice, informing many medical decisions. Physicians will increasingly rely on companion and other types of lab diagnostics that consider genetic, proteomic, or other markers in connection with drug treatment strategies.
Top ways to tap value from specialty drugs for chronic careThe next stage of chronic care management and value-based insurance design for the continuing onslaught of high-priced specialty drugs, including PCSK9 inhibitors.
[BLOG]: Obesity drug safety review
[BLOG]: Obesity drug safety reviewIn this blog post, Robert Kyle of AdverseEvents compares the results of a postmarket survey of 3 obesity drugs.
[BLOG]: 741 drugs in antibiotics pipeline, few first-in-classAntibiotic resistance has grown at an alarming rate over the last few decades. To prevent a post-antibiotic era in which common infections could become lethal, an estimated 20 novel families of antibiotics must be developed in the next 50 years. Political groups in both the U.S. and Europe are each working to promote new development, but there are concerns the results may not come in time.
[BLOG]: Big pharma and the new trend of acquisitionsBiologic and pharmaceutical companies, along with their financial advisors or venture capital partners, have used mergers and acquisitions over the years to create value to keep their leading positions in a changing market. The era of pharmaceutical companies relying on blockbusters for their growth is over as more and more of these drugs have faced patent expiration, with no indication that new medicinal discoveries will emerge to take their place.
[BLOG]: Clinical pharmacogenomics: Meeting the needs of the community through a dedicated clinic
[BLOG]: Clinical pharmacogenomics: Meeting the needs of the community through a dedicated clinicBLOG: Pharmacogenomics is the study of how DNA differences affect response to medications. This can explain why similar patients have different reactions to the same medication even if they receive the same dosage. The pharmacogenomics clinic at NorthShore is the first step toward a larger implementation.